🇨🇳 China Clinical Trials Database
Search 109,000+ clinical trials conducted in China. Access comprehensive trial data including phases, sponsors, outcomes, and locations from Chinese Clinical Trial Registry (ChiCTR). Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the China clinical trials database?
The China clinical trials database contains over 109,000 clinical trials registered in China, primarily through the Chinese Clinical Trial Registry (ChiCTR) and international registries. China is the second-largest market for clinical trials globally.
How do I search for clinical trials in China?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. You can filter results by phase, status, and intervention type to find relevant Chinese clinical research.
What regulatory body oversees clinical trials in China?
The National Medical Products Administration (NMPA, formerly CFDA) oversees clinical trials in China. The Chinese Clinical Trial Registry (ChiCTR) is the official WHO-recognized registry for Chinese trials.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies understand the Chinese clinical trial landscape.
Are traditional Chinese medicine trials included?
Yes, the database includes trials for traditional Chinese medicine (TCM), Western pharmaceuticals, medical devices, biologics, and combination therapies registered in China.
How does China clinical trial data compare globally?
China conducts the second-highest number of clinical trials globally after the United States. The database covers trials from academic institutions, pharmaceutical companies, and government-sponsored research.
About This Database
This database provides free access to clinical trial data from China. The Chinese Clinical Trial Registry (ChiCTR) is a WHO-recognized primary registry. Use this tool to research the Chinese pharmaceutical market, find partnership opportunities, understand NMPA requirements, and track drug/device development in the world's second-largest healthcare market.